Non-coding RNAs: a new frontier in benzene-mediated toxicity

AHS Nia, M Reyhani-Ardabili, M Sheikhvand… - Toxicology, 2023 - Elsevier
One of the most frequent environmental contaminants, benzene is still widely used as an
industrial solvent around the world, especially in developing nations, posing a serious …

Profiling Small RNA From Brain Extracellular Vesicles in Individuals With Depression

P Ibrahim, R Denniston, H Mitsuhashi… - International Journal …, 2024 - academic.oup.com
Background Major depressive disorder (MDD) is a leading cause of disability with significant
mortality risk. Despite progress in our understanding of the etiology of MDD, the underlying …

[HTML][HTML] Environmental enrichment attenuates depressive-like behavior in maternal rats by inhibiting neuroinflammation and apoptosis and promoting neuroplasticity

G Chen, Y Zhang, R Li, L Jin, K Hao, J Rong… - Neurobiology of …, 2024 - Elsevier
Gestational stress can exacerbate postpartum depression (PPD), for which treatment options
remain limited. Environmental enrichment (EE) may be a therapeutic intervention for …

Kétamine et suicidalité: modèles animaux pour comprendre son mécanisme d'action

TML Nguyen, F Jollant, L Tritschler, R Colle… - Annales …, 2023 - Elsevier
Highlights•More than two thirds of suicides occur during a major depressive episode.•The
impulsive-aggressive dimensions are vulnerability factors associated with suicide in these …

[HTML][HTML] From microRNA to protein, linking the neurotrophic hypothesis of depression to the Wistar Kyoto rat

E Kaadt, NK Hedemann, CK Damgaard, HK Müller… - Neuroscience …, 2023 - Elsevier
Animal models of depression offer an alternative research-platform to clinical studies where
limitations such as incomplete medical histories, patient heterogeneity, and difficulty tracking …

MicroRNAs underlying the antidepressant effect of psilocybin–Establishing an nCounter pipeline for microRNA-quantification in the pig brain

E Kaadt, R Søkilde, H Hansen, N Raval, L Lundgaard… - 2024 - researchsquare.com
Novel treatment strategies are needed to overcome some of the current challenges related
to treatment resistance and treatment latency within the psychiatric field. Recently, psilocybin …